Precision, long-chain DNA.
Remarkable efficiency. No compromises.
No compromises.

NEWS

ABOUT US

Synplogen is a DNA synthesis startup spun out of Kobe University's
Graduate School of Science, Technology and Innovation. Through intelligent
cross-disciplinary integration of genetic engineering, information science
and robotics, Synplogen is able to quickly and efficiently synthesize traditionally
challenging DNA products. Synplogen applies this technology in its DNA synthesis
service, as well as development of specialty vectors for gene therapy applications.

TECHNOLOGY

OGAB, one of Synplogen's core synthesis technologies, allows for quick and easy assembly of up to 50 DNA fragments, resulting in strands of 100kbp or more with an exceptionally high rate of success. Synplogen also possesses technologies for the development of viral vectors for use in gene therepy, as well as Combi-OGAB, a combinatorial technique for the creation of high quality libraries with tens of thousands of sequences from just a single reaction.

TECHNOLOGY

DNA
SYNTHESIS

From oligo to plasmid, Synplogen offers competitive prices and turnaround times for traditionally challenging DNA, including long-chain, high GC content, high AC content, highly repetitive sequences.

DNA SYNTHESIS

GENE
THERAPY

Development of gene therapy techniques has been accelarating as a new modality for the treatment of traditionally challenging diseases. Synplogen is building the capacity for DNA synthesis as well as viral vector production all under one roof, quickly and effectively meeting your viral vector needs.

GENE THERAPY

COMPANY

Synplogen

Precision, long-chain DNA.
Remarkable efficiency.
No compromises.

ORDER FORM

Contact us regarding our DNA synthesis services.

JOIN

Apply to join our growing team.

CONTACT

For orders or consultation,
or for enquiries regarding our technology or
partnership opportunities,
please contact us using the form below.